Agency Forms Undergoing Paperwork Reduction Act Review, 31379 [2015-13161]
Download as PDF
<![CDATA[
31379
Federal Register / Vol. 80, No. 105 / Tuesday, June 2, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–15–15UR]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Enhanced Surveillance of
Coccidioidomycosis in Low- and NonEndemic States—New—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Coccidioidomycosis, also called
‘‘Valley fever,’’ is a nationally notifiable
fungal infection caused by inhalation of
soil-dwelling Coccidioides spp. In the
United States, coccidioidomycosis is
known to be endemic in the
southwestern states, but new evidence
suggests that the true endemic areas
may be broader than previously
recognized. Approximately 10,000
coccidioidomycosis cases are reported
in the U.S. each year to the National
Notifiable Disease Surveillance System
(NNDSS), but this system captures
limited clinical and epidemiological
information about reported cases. Most
cases occur in Arizona or California, so
the epidemiology of this disease has
been well-described for these states, but
little is known about the features of
cases in other states.
Enhanced surveillance in low- and
non-endemic states will help determine
which information is most important to
collect during routine surveillance and
will help assess the suitability of the
Council of State and Territorial
Epidemiologists (CSTE) case definition
for coccidioidomycosis in these areas.
Primary prevention strategies for
coccidioidomycosis have not yet been
proven to be effective, so public health
efforts may be best aimed at promoting
awareness of coccidioidomycosis among
healthcare providers and the general
public. Improved surveillance data are
essential for identifying such
opportunities to promote awareness
about this disease and for determining
its true public health burden.
State health department personnel in
participating low- and non-endemic
states will conduct telephone interviews
with coccidioidomycosis cases reported
during one calendar year that meet the
CSTE case definition and will record
responses on a standardized form. State
health department personnel will use
the form to collect information on
demographics, underlying medical
conditions, travel history, symptom type
and duration, healthcare-seeking
behaviors, diagnosis, treatment, and
outcomes.
OMB approval is requested for two
years. Participation is voluntary. The
total estimated annualized burden is 48
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
State Health Department Personnel ...............
Case Report Form for Coccidioidomycosis
(Valley Fever) Enhanced Surveillance.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2015–13161 Filed 6–1–15; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
VerDate Sep<11>2014
17:26 Jun 01, 2015
Jkt 235001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
145
Number of
responses per
respondent
1
Average
burden per
response
(in hrs.)
20/60
review of applications in response to
Funding Opportunity Announcement,
RFA–EH–15–002, Development and
validation of laboratory procedures
using next generation sequencing
technologies to assess genes causing
severe combined immune deficiency
(SCID) in state newborn screening
laboratories.
Times and Dates: 11:00 a.m.–3:00
p.m., EDT, June 25, 2015 (CLOSED).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)(4)
E:\FR\FM\02JNN1.SGM
02JNN1
]]>Agencies
[Federal Register Volume 80, Number 105 (Tuesday, June 2, 2015)]
[Notices]
[Page 31379]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13161]
[[Page 31379]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-15UR]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Enhanced Surveillance of Coccidioidomycosis in Low- and Non-Endemic
States--New--National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Coccidioidomycosis, also called ``Valley fever,'' is a nationally
notifiable fungal infection caused by inhalation of soil-dwelling
Coccidioides spp. In the United States, coccidioidomycosis is known to
be endemic in the southwestern states, but new evidence suggests that
the true endemic areas may be broader than previously recognized.
Approximately 10,000 coccidioidomycosis cases are reported in the U.S.
each year to the National Notifiable Disease Surveillance System
(NNDSS), but this system captures limited clinical and epidemiological
information about reported cases. Most cases occur in Arizona or
California, so the epidemiology of this disease has been well-described
for these states, but little is known about the features of cases in
other states.
Enhanced surveillance in low- and non-endemic states will help
determine which information is most important to collect during routine
surveillance and will help assess the suitability of the Council of
State and Territorial Epidemiologists (CSTE) case definition for
coccidioidomycosis in these areas. Primary prevention strategies for
coccidioidomycosis have not yet been proven to be effective, so public
health efforts may be best aimed at promoting awareness of
coccidioidomycosis among healthcare providers and the general public.
Improved surveillance data are essential for identifying such
opportunities to promote awareness about this disease and for
determining its true public health burden.
State health department personnel in participating low- and non-
endemic states will conduct telephone interviews with
coccidioidomycosis cases reported during one calendar year that meet
the CSTE case definition and will record responses on a standardized
form. State health department personnel will use the form to collect
information on demographics, underlying medical conditions, travel
history, symptom type and duration, healthcare-seeking behaviors,
diagnosis, treatment, and outcomes.
OMB approval is requested for two years. Participation is
voluntary. The total estimated annualized burden is 48 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
State Health Department Personnel.. Case Report Form for 145 1 20/60
Coccidioidomycosis (Valley
Fever) Enhanced
Surveillance.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-13161 Filed 6-1-15; 8:45 am]
BILLING CODE 4163-18-P
